Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms Journal Article


Authors: Bernard, L.; Belisle, C.; Mollica, L.; Provost, S.; Roy, D. C.; Gilliland, D. G.; Levine, R. L.; Busque, L.
Article Title: Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
Abstract: Myeloproliferative neoplasms (MPNs) are clonal stem cell disorders characterized by chronic proliferation of hematopoietic progenitors. We studied the telomere length (TL) of 335 MPN patients and 93 gender- and age-matched controls using a quantitative PCR method (relative TL calculated as the ratio of the amount of telomere DNA vs single-copy DNA: T/S ratio). TL was markedly reduced in MPN patients compared with controls (T/S 0.561 vs 0.990, P<0.001). In JAK2V617F MPN patients, TL correlated inversely with allelic burden (P<0.001). Patients homozygous for the mutation (allelic burden 90-100%) had the shortest TL, even when compared with patients with lower allele burdens consistent with a dominant heterozygous population (allelic burden 55-65%) (T/S 0.367 vs 0.497, P=0.037). This suggests that the high degree of proliferation of the MPN clone reduces TL and suggests the possibility that TL shortening may be indicative of progressive genomic instability during MPN progression. The TL of JAK2V617F-negative MPN patients was similar to JAK2V617F-positive counterparts (T/S 0.527 vs 0.507, P=0.603), suggesting that the yet-to-be-discovered causative mutation(s) impact the mutated stem cell similarly to JAK2V617F, and that TL measurement may prove useful in the diagnostic workup of JAK2V617F-negative MPN.
Keywords: adult; controlled study; myeloproliferative disorders; gene mutation; major clinical study; myeloproliferative disorder; case-control studies; mutation, missense; janus kinase 2; disease course; diagnostic accuracy; polymerase chain reaction; cell proliferation; telomere; allele; cohort analysis; genotype; stem cell; homozygosity; correlation analysis; disease severity; clonal variation; diagnostic value; janus kinase; genomic instability; heterozygosity; quantitative analysis; disease progression
Journal Title: Leukemia
Volume: 23
Issue: 2
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2009-02-01
Start Page: 287
End Page: 291
Language: English
DOI: 10.1038/leu.2008.319
PUBMED: 19005480
PROVIDER: scopus
PMCID: PMC4640467
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: LEUKE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine